Genetics has revolutionised patient selection for clinical trials

Genetics is questioning the wisdom behind the old gold standard of randomised populations used for trials. While large randomised trials avoid bias, personalised medicine trials are limited by their small size, but could be more focussed and effective based on the genetics of the patient, informsĀ Dr Suresh Subramani, Global Director, Tata Institute for Genetics and Society and Distinguished Professor, University of California San Diego